Syntium Pharmaceuticals Inc. is a biopharmaceutical company. Our business model is to in-license early stage candidate drugs (in preclinical or early clinical stages) and to move these down the value chain through clinical development up to Proof-of-Concept in the target patient population. Thereafter, we out-licence these late stage candidate drugs.
What We Do
We actively in-license drug candidates.
We conduct and fund the clinical development of these candidates up to clinical Proof-of-Concept.
We out-license these candidate drugs with Proof-of-Concept data.
We have added seasoned drug developers to our team.